Invention Application
US20160252527A1 ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS
审中-公开
用于确定等离子体KALLIKREIN系统生物标志物的测定
- Patent Title: ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS
- Patent Title (中): 用于确定等离子体KALLIKREIN系统生物标志物的测定
-
Application No.: US15030811Application Date: 2014-10-17
-
Publication No.: US20160252527A1Publication Date: 2016-09-01
- Inventor: Daniel J. Sexton , Ryan Faucette , Jon A. Kenniston , Gregory P. Conley , Andrew Nixon , Christopher TenHoor , Burt Adelman
- Applicant: DYAX CORP.
- Applicant Address: US MA Burlington
- Assignee: Dyax Corp.
- Current Assignee: Dyax Corp.
- Current Assignee Address: US MA Burlington
- International Application: PCT/US14/61247 WO 20141017
- Main IPC: G01N33/68
- IPC: G01N33/68 ; C07K16/40 ; C12Q1/37
Abstract:
Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.
Public/Granted literature
- US11372002B2 Assays for determining plasma kallikrein system biomarkers Public/Granted day:2022-06-28
Information query
IPC分类:
